Navigation Links
Georgetown professor applauds decision of researchers to temporarily halt research on H5N1
Date:1/23/2012

WASHINGTON, DC A Georgetown University Medical Center professor says the voluntary action taken by two research teams to temporarily halt work involving the highly pathogenic avian influenza H5N1 is "laudable."

In the researchers' statement, published today by Science and Nature, the authors stated that they "recognize that we and the rest of the scientific community need to clearly explain the benefits of this important research and the measures taken to minimize its possible risks." The statement comes in the wake of a debate following the U.S. government's request that Science and Nature withhold scientific information related to the genetically modified H5N1 virus because of biosecurity concerns.

"This is a laudable decision to make sure that all voices are heard on such an important issue," says John D. Kraemer, JD, MPH, assistant professor of health systems administration at Georgetown University School of Nursing & Health Studies. Trained in both public health and the law, Kraemer conducts scholarship on public health law and ethics, with a particular focus on the ethical and legal limits of governmental action to address health concerns.

"The moratorium will provide an opportunity for institutions to assess the best way of overseeing dual use research that which has both significant potential for public health benefits and a chance for harm," he adds.

In 2011, two research teams one from the United States and one from the Netherlands announced that they had genetically modified the H5N1 avian influenza virus in such a way that it could possibly spread rapidly among humans. They estimated that half of those who would contract the engineered virus would die (the research was conducted in an animal model believed to represent human behavior of the virus). Their work, funded by the National Institutes of Health (NIH), was submitted independently to the journals Nature and Science for publication. The National Science Advisory Board for Biosecurity (NSABB), which advises the Department of Health and Human Services (HHS), recommended that Science and Nature redact key information prior to publication out of concern that published details about the papers' methodology and results could become a blueprint for bioterrorism.

On January 19, Kraemer and his colleague, Lawrence O. Gostin, the Linda D. and Timothy J. O'Neill Professor of Global Health Law at Georgetown University Law Center, published an invited opinion on the topic for Science's "Policy Forum." ("The Limits of Government Regulation of Science" 19 Jan 2012).

In it, Kraemer and Gostin said the U.S. government's request that the journals Science and Nature withhold that scientific information does not violate the First Amendment. They advised, however, that a fair, transparent process undertaken by research organizations is preferable to governmental constraints on disseminating scientific information.

"The NSABB process seems to have worked well in this instance," says Kraemer. "It raised legitimate security concerns while avoiding censorship of the scientific press. But there remains a need to strengthen precautions around this type of research before scientific censorship occurs."


'/>"/>

Contact: Karen Mallet
km463@georgetown.edu
Georgetown University Medical Center
Source:Eurekalert

Related medicine news :

1. Georgetown researchers examine 21-year series of nipple sparing mastectomy cases and find no cancers
2. FDA awards Georgetown University a Center of Excellence in Regulatory Science & Innovation
3. Georgetown research identifies key reasons racial disparities exist in emergent stroke treatment
4. FDA and Georgetown University Medical Center announce partnership
5. Georgetown Research Center Helps Reporters Decipher Health Reform Law & Impact on State Residents
6. Georgetown University Center for Children and Families Hails Health Reform As Big Win for Children and Families
7. NSF grant will aid Wayne State professors mathematical modeling of fatty liver predictors
8. Louisiana Tech professor co-edits book on computational analysis of human eye
9. New book by University of Louisville professor enables reader to develop personalized anti-depression plan
10. Professor Doug Hilton wins Research Australia Award
11. Cell death research wins professor Andreas Strasser 2011 Victoria Prize
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... autologous fat (adipose) transfer systems announces the issuance of United States Patent Number ... for its adipose filtration technology. The '398 and '324 patents cover methods ...
(Date:7/24/2017)... Georgia (PRWEB) , ... July 24, 2017 , ... ... comprehensive sleep management solution focused on delivering end-to-end sleep health care ... program. , Recent literature shows that adherence rates for positive airway pressure (PAP) ...
(Date:7/24/2017)... ... July 24, 2017 , ... Committed to ... have enrolled over 100,000 children in their treatment program. Clubfoot is a pervasive ... areas where treatment is limited or non-existent. Without intervention, these children are destined ...
(Date:7/24/2017)... Shandong Province (PRWEB) , ... July 24, 2017 ... ... Chinese Medicine's "Chinese Medicine Clinical Vitiligo Hospital" was set up, and the awarding ... Administration of traditional Chinese medicine, the head of the army's health system, and ...
(Date:7/24/2017)... ... 24, 2017 , ... “A Short Walk to the Mailbox”: a remarkable memoir ... of published author, Ed Clark. Ed Clark is a church music director and ... a minister of music and worship leader for over fifty years. He has ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)...  The tenth annual BioPharm America™ will ... at the Sheraton Boston Hotel, September 26–27. The event ... decision makers and innovative biotech startup companies. The event ... two impactful days. BioPharm America is now part of ... opportunities with 4,500+ life science industry influencers participating in ...
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... company focused on the development of oral drug delivery systems, ... Securities Authority to dual-list its common stock on the Tel ... on the TASE on July 12, 2017 under the ticker ... it is expected that Oramed will be included in the ...
(Date:6/30/2017)... ROCKVILLE, Md. , June 30, 2017 ... that since the start of May, at least ten ... financings include private investments, public offerings and a loan ... $3.3 million to almost $80 million.  Kalorama Information provides ... customers of its Diagnostics Knowledge Center. ...
Breaking Medicine Technology: